Literature DB >> 23460391

[Drug-induced malignant arrhythmias. IT prevents lethal drug mixtures].

S Thaler1, C Neumeier, G Flury.   

Abstract

We report a case of nearly fatal ventricular tachyarrhythmia type Torsade de pointes caused by medication-induced prolongation of QTc duration (methadone, ondansetron, escitalopram). The etiology, pathophysiology, and trigger mechanisms of such malignant arrhythmias are discussed. In order to prevent similar iatrogenic complications in the future, we networked the qtdrug database with our medication interaction control program and installed an automatic electronic warning system for the physicians in charge in case of a digitally recorded prolonged QTc duration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460391     DOI: 10.1007/s00108-013-3246-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  10 in total

Review 1.  Drug-induced prolongation of the QT interval.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

Review 2.  Molecular physiology of cardiac repolarization.

Authors:  Jeanne M Nerbonne; Robert S Kass
Journal:  Physiol Rev       Date:  2005-10       Impact factor: 37.312

3.  Duration of QRS complex in resting electrocardiogram is a predictor of sudden cardiac death in men.

Authors:  Sudhir Kurl; Timo H Mäkikallio; Pentti Rautaharju; Vesa Kiviniemi; Jari A Laukkanen
Journal:  Circulation       Date:  2012-05-21       Impact factor: 29.690

Review 4.  Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Authors:  Chin B Eap; Thierry Buclin; Pierre Baumann
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.

Authors:  Georg B Ehret; Cathy Voide; Marianne Gex-Fabry; Jocelyne Chabert; Dipen Shah; Barbara Broers; Valérie Piguet; Thierry Musset; Jean-Michel Gaspoz; Arnaud Perrier; Pierre Dayer; Jules A Desmeules
Journal:  Arch Intern Med       Date:  2006-06-26

6.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

7.  Methadone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983-1999.

Authors:  Gérard Niveau; Anne-Laure Rougemont; Romano La Harpe
Journal:  Eur J Public Health       Date:  2002-09       Impact factor: 3.367

8.  Torsade de pointes associated with very-high-dose methadone.

Authors:  Mori J Krantz; Laurent Lewkowiez; Helen Hays; Mary Ann Woodroffe; Alastair D Robertson; Philip S Mehler
Journal:  Ann Intern Med       Date:  2002-09-17       Impact factor: 25.391

Review 9.  Methadone-associated Q-T interval prolongation and torsades de pointes.

Authors:  John Stringer; Christopher Welsh; Anthony Tommasello
Journal:  Am J Health Syst Pharm       Date:  2009-05-01       Impact factor: 2.637

10.  QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

Authors:  Erich F Wedam; George E Bigelow; Rolley E Johnson; Paul A Nuzzo; Mark C P Haigney
Journal:  Arch Intern Med       Date:  2007-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.